Lower Costs, More Transparency Act of 2026
Key claim: The Lower Costs, More Transparency Act of 2026 (HR9393) was ordered to be reported in the nature of a substitute by a unanimous 45–0 committee vote.
Abstract
(HR9393 · 119th Congress) Latest action (2026-07-21): Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 45 - 0.
Why this matters
A unanimous 45–0 committee ordered-report signals bipartisan momentum on healthcare cost and transparency policy, increasing the likelihood the bill reaches the House floor. For patients and insurers, the eventual substitute text could reshape what providers must disclose about prices and how prescription drug costs are managed, though the practical effect depends on provisions not yet public.